S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
OTCMKTS:BSTG

Biostage News Headlines

$3.26
+0.06 (+1.88 %)
(As of 09/23/2021 11:08 AM ET)
Add
Compare
Today's Range
$3.26
$3.80
50-Day Range
$1.21
$4.08
52-Week Range
$0.55
$4.49
Volume800 shs
Average Volume3,686 shs
Market Capitalization$31.58 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.28

Media Mentions By Week

Biostage Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BSTG
News Sentiment

0.00

0.35

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BSTG Articles
This Week

1

0

BSTG Articles
Average Week

Get Biostage News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSTG and its competitors with MarketBeat's FREE daily newsletter.

Biostage (OTCMKTS BSTG) News Headlines Today

SourceHeadline
Biostage (OTCMKTS:BSTG) & Bioventus (NYSE:BVS) Head to Head ComparisonBiostage (OTCMKTS:BSTG) & Bioventus (NYSE:BVS) Head to Head Comparison
americanbankingnews.com - September 25 at 1:16 PM
Biostage, Inc. (OTCMKTS:BSTG) Sees Significant Growth in Short InterestBiostage, Inc. (OTCMKTS:BSTG) Sees Significant Growth in Short Interest
americanbankingnews.com - September 14 at 11:56 AM
Biostage™ Appoints Jerry He to Board of Directors and Completes Private Placement of $2.6 Million to Continue Its Clinical TransitionBiostage™ Appoints Jerry He to Board of Directors and Completes Private Placement of $2.6 Million to Continue Its Clinical Transition
finance.yahoo.com - September 8 at 9:44 AM
Biostage Reports Q2 2021 Financial ResultsBiostage Reports Q2 2021 Financial Results
finance.yahoo.com - August 13 at 4:45 PM
Biostage Reports Q1 2021 Financial ResultsBiostage Reports Q1 2021 Financial Results
finance.yahoo.com - May 24 at 5:05 PM
Biostage Reports 2020 Financial Results and Appointment of Interim Vice President of FinanceBiostage Reports 2020 Financial Results and Appointment of Interim Vice President of Finance
finance.yahoo.com - April 13 at 5:39 PM
Biostage Strengthens Board of Directors with Appointment of Herman SanchezBiostage Strengthens Board of Directors with Appointment of Herman Sanchez
finance.yahoo.com - January 25 at 1:04 PM
Biostage Reports Third Quarter 2020 Financial ResultsBiostage Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 13 at 7:33 PM
Biostage Reports Second Quarter 2020 Financial ResultsBiostage Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 13 at 11:52 PM
Biostage Inc.Biostage Inc.
www.marketwatch.com - July 4 at 12:52 AM
Biostage Reports First Quarter 2020 Financial ResultsBiostage Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 14 at 7:59 PM
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of DirectorsMr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
www.bloomberg.com - April 25 at 12:53 AM
Biostage Reports 2019 Financial ResultsBiostage Reports 2019 Financial Results
finance.yahoo.com - March 27 at 6:23 PM
FDA OKs Biostages IND for Cellspan Esophageal ImplantFDA OKs Biostage's IND for Cellspan Esophageal Implant
seekingalpha.com - March 20 at 8:21 AM
Biostage Announces IND Approval from FDA for its Lead Product Candidate Cellspan™ Esophageal ImplantBiostage Announces IND Approval from FDA for its Lead Product Candidate Cellspan™ Esophageal Implant
finance.yahoo.com - March 20 at 8:21 AM
Biostage Submitted Official Response to FDA for Investigational New Drug Application for its Lead Product Candidate Cellspan™ Esophageal ImplantBiostage Submitted Official Response to FDA for Investigational New Drug Application for its Lead Product Candidate Cellspan™ Esophageal Implant
finance.yahoo.com - February 20 at 7:12 PM
Biostage Reports 2018 First Quarter Financial ResultsBiostage Reports 2018 First Quarter Financial Results
www.bloomberg.com - February 18 at 6:40 PM
Biostage Provides Update on FDA Investigational New Drug Application for its Lead Product Candidate Cellspan™ Esophageal ImplantBiostage Provides Update on FDA Investigational New Drug Application for its Lead Product Candidate Cellspan™ Esophageal Implant
finance.yahoo.com - January 2 at 9:01 PM
Biostage, Inc. Discusses Potential Clinical Trials for Their Next-Generation Esophageal ImplantsBiostage, Inc. Discusses Potential Clinical Trials for Their Next-Generation Esophageal Implants
finance.yahoo.com - November 25 at 3:34 PM
Biostage Reports Third Quarter 2019 Financial ResultsBiostage Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 12 at 8:12 AM
­­Biostage to Host Conference Call to Discuss Third Quarter 2019 Financial Results and Business Update­­Biostage to Host Conference Call to Discuss Third Quarter 2019 Financial Results and Business Update
finance.yahoo.com - November 6 at 8:21 PM
Biostage Submits Investigational New Drug (IND) Application for Lead Product Candidate Cellspan™ Esophageal Implant for Treatment of Esophageal ConditionsBiostage Submits Investigational New Drug (IND) Application for Lead Product Candidate Cellspan™ Esophageal Implant for Treatment of Esophageal Conditions
finance.yahoo.com - October 30 at 8:23 AM
Biostage, Inc. Joins the Stock Day Podcast to Discuss Their Pending FDA ApplicationBiostage, Inc. Joins the Stock Day Podcast to Discuss Their Pending FDA Application
finance.yahoo.com - September 3 at 12:42 PM
Biostage, Inc. (BSTG) CEO Jim McGorry on Q2 2019 Results - Earnings Call TranscriptBiostage, Inc. (BSTG) CEO Jim McGorry on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 13 at 4:09 PM
Biostage to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Business UpdateBiostage to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Business Update
finance.yahoo.com - August 7 at 6:24 PM
Biostage, Inc. (BSTG) CEO Jim McGorry on Q1 2019 Results - Earnings Call TranscriptBiostage, Inc. (BSTG) CEO Jim McGorry on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 12:18 PM
Biostage Inc (BSTG) CEO Jim McGorry on Q4 2018 Results - Earnings Call TranscriptBiostage Inc (BSTG) CEO Jim McGorry on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 28 at 4:03 PM
Biostage to Host Conference Call to Discuss 2018 Financial Results and Business UpdateBiostage to Host Conference Call to Discuss 2018 Financial Results and Business Update
finance.yahoo.com - March 22 at 12:11 PM
Get Biostage News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSTG and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.